Usually the prognosis of stage Ic lung adenocarcinoma is better, with a 5-year survival rate of about 70% and a low recurrence rate of about 30%.
Lung adenocarcinoma belongs to a group of non-small cell lung cancer, and the disease progresses slowly. According to TNM staging, stage Ic lung adenocarcinoma belongs to the early stage of the disease, and usually, stage Ic lung adenocarcinoma has a better prognosis after timely and standardized treatment. The 5-year survival rate is often used to roughly assess the survival of patients, and the 5-year survival rate of this stage is about 70%.
Moreover, the recurrence rate of stage Ic lung adenocarcinoma is not high, about 30%, and the quality of life of patients is high. However, there is obvious individual variability in the specific prognosis, which is related to the patient’s physical status, treatment method and other factors. Secondly, patients should review on time and adhere to long-term follow-up.
In summary, patients with stage Ic lung adenocarcinoma need to strengthen daily life management, cooperate with doctors for active treatment as early as possible, and have regular follow-up.